Suppr超能文献

能否覆水难收?影响癌症筛查决策的情感因素定性研究。

Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions.

机构信息

Community Health Sciences, College of Medicine, Faculty of Health Sciences, University of Manitoba, S113-750 Bannatyne Avenue, Winnipeg, MB, R3E 0W3, Canada.

Department of Oncology, McMaster University, Juravinski Site, 60 (G) Wing, 711 Concession Street, Hamilton, ON, L8V 1C3, Canada.

出版信息

BMC Cancer. 2017 Sep 13;17(1):647. doi: 10.1186/s12885-017-3596-7.

Abstract

BACKGROUND

The belief that early detection is the best protection against cancer underlies cancer screening. Emerging research now suggests harms associated with early detection may sometimes outweigh the benefits. Governments, cancer agencies, and organizations that publish screening guidelines have found it is difficult to "un-ring the bell" on the message that "early detection is your best protection" because of its widespread communication and enduring resonance. This study explores affective factors-and their interplay with relevant analytical factors-in public/laypersons' decision making about cancer screening.

METHODS

A total of 93 people (47 men, 46 women) attended focus groups about, respectively, prostate cancer screening and breast cancer screening in two Canadian cities.

RESULTS

Affective factors were a major influence on many focus group participants' decision making about cancer screening, including fear of cancer and a generalized enthusiasm for prevention/screening, and they were often inspired by anecdotes about the cancer experiences of family and friends. Affect also existed alongside more analytical factors including assessments of reduced risk in the management of any cancer diagnosis if caught early, and, for men, the belief that an unreliable test is "better than nothing," and that men deserve prostate cancer screening because women have breast and cervical cancer screening. Affective factors were particularly noticeable in the sub-groups most supportive of screening and the "early detection" message: older women who felt that mammogram screening should begin at age 40 rather than 50, and older men who felt that prostate cancer screening should be expanded beyond its current unorganized, opportunistic usage. In contrast, younger participants displayed less affective attachments to "early detection" messages and had greater concerns about harms of screening and were more receptive to nuanced messages informed by evidence.

CONCLUSION

Policymakers attempting to communicate more nuanced versions of the "early detection" message need to understand the role of affect alongside other judgments brought into laypersons' decision making processes and anticipate how affective responses to their messages will be shaped, transformed, and potentially subverted by external forces beyond their control. Particularly overt external factors are campaigns by cancer advocacy organizations actively promoting breast and prostate cancer awareness and screening to younger women and men using affectively-charged messages.

摘要

背景

癌症筛查的基础是相信早期检测是预防癌症的最佳方法。新的研究表明,早期检测的危害有时可能超过其益处。政府、癌症机构和发布筛查指南的组织发现,由于“早期检测是您的最佳保护”这一信息已经广泛传播并产生了持久的共鸣,因此很难“取消”这一信息。本研究探讨了公众/非专业人士在癌症筛查决策中的情感因素及其与相关分析因素的相互作用。

方法

共有 93 人(47 名男性,46 名女性)参加了在加拿大两个城市举行的关于前列腺癌筛查和乳腺癌筛查的焦点小组。

结果

情感因素对许多焦点小组参与者的癌症筛查决策产生了重大影响,包括对癌症的恐惧和对预防/筛查的普遍热情,并且他们常常受到家人和朋友癌症经历的故事的启发。情感因素也与其他分析因素并存,包括对早期发现任何癌症诊断时降低风险的评估,以及对于男性来说,他们认为不可靠的检测“总比没有好”,并且男性应该进行前列腺癌筛查,因为女性有乳腺癌和宫颈癌筛查。在最支持筛查和“早期检测”信息的亚组中,情感因素尤为明显:认为乳房 X 光筛查应该从 40 岁而不是 50 岁开始的老年女性,以及认为应该扩大前列腺癌筛查范围的老年男性超出目前无组织、机会性使用的范围。相比之下,年轻参与者对“早期检测”信息的情感依恋较少,对筛查的危害更加关注,并且更容易接受基于证据的细致入微的信息。

结论

试图传达更细致入微的“早期检测”信息的政策制定者需要了解情感因素在非专业人士决策过程中的作用,以及如何预测他们的信息将如何受到外部力量的影响、改变和潜在颠覆,而这些外部力量是他们无法控制的。特别明显的外部因素是癌症宣传组织开展的活动,这些组织通过使用情感化的信息,积极向年轻女性和男性宣传乳腺癌和前列腺癌意识和筛查。

相似文献

1
Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions.
BMC Cancer. 2017 Sep 13;17(1):647. doi: 10.1186/s12885-017-3596-7.
2
Association of time intervals in cancer screenings and older participants' characteristics, in a nationally representative sample.
J Geriatr Oncol. 2023 Jan;14(1):101392. doi: 10.1016/j.jgo.2022.10.007. Epub 2022 Nov 4.
3
Engaging Patients in Decisions About Cancer Screening: Exploring the Decision Journey Through the Use of a Patient Portal.
Am J Prev Med. 2018 Feb;54(2):237-247. doi: 10.1016/j.amepre.2017.10.027. Epub 2017 Dec 11.
4
Uninformed compliance or informed choice? A needed shift in our approach to cancer screening.
J Natl Cancer Inst. 2011 Dec 21;103(24):1821-6. doi: 10.1093/jnci/djr474. Epub 2011 Nov 21.
6
Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Ann Intern Med. 2013 May 21;158(10):761-769. doi: 10.7326/0003-4819-158-10-201305210-00633.
7
Decision-making about mammographic screening: pursuing informed choice.
Climacteric. 2018 Jun;21(3):209-213. doi: 10.1080/13697137.2017.1406912. Epub 2018 Feb 8.
8
Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
Eur J Public Health. 2014 Apr;24(2):264-70. doi: 10.1093/eurpub/ckt089. Epub 2013 Jun 27.
9
Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey.
Med Decis Making. 2010 Sep-Oct;30(5 Suppl):53S-64S. doi: 10.1177/0272989X10378701.
10

引用本文的文献

4
Risk-Adapted Breast Screening for Women at Low Predicted Risk of Breast Cancer: An Online Discrete Choice Experiment.
Med Decis Making. 2024 Jul;44(5):586-600. doi: 10.1177/0272989X241254828. Epub 2024 Jun 3.
6
Clinical and psychosocial constructs for breast, cervical, and colorectal cancer screening participation: A systematic review.
Int J Clin Health Psychol. 2023 Apr-Jun;23(2):100354. doi: 10.1016/j.ijchp.2022.100354. Epub 2022 Nov 18.
7
'Is it painful'? A qualitative study on experiences of patients before prostate needle biopsy.
BMJ Open. 2022 Sep 8;12(9):e056619. doi: 10.1136/bmjopen-2021-056619.
9
Factors promoting breast, cervical and colorectal cancer screenings participation: A systematic review.
Psychooncology. 2022 Sep;31(9):1435-1447. doi: 10.1002/pon.5997. Epub 2022 Jul 12.
10
The Influence of Emotions on Treatment Decisions About Low-Risk Thyroid Cancer: A Qualitative Study.
Thyroid. 2021 Dec;31(12):1800-1807. doi: 10.1089/thy.2021.0323. Epub 2021 Nov 26.

本文引用的文献

1
Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening.
CMAJ Open. 2016 Mar 2;4(1):E73-9. doi: 10.9778/cmajo.20140079. eCollection 2016 Jan-Mar.
2
Recommendations on screening for prostate cancer with the prostate-specific antigen test.
CMAJ. 2014 Nov 4;186(16):1225-34. doi: 10.1503/cmaj.140703. Epub 2014 Oct 27.
3
Prostate cancer screening: going beyond the clinical evidence.
CMAJ. 2014 Nov 4;186(16):1201-2. doi: 10.1503/cmaj.141252. Epub 2014 Oct 27.
4
Lack of shared decision making in cancer screening discussions: results from a national survey.
Am J Prev Med. 2014 Sep;47(3):251-9. doi: 10.1016/j.amepre.2014.04.011. Epub 2014 Jun 9.
5
Breast cancer screening pamphlets mislead women.
BMJ. 2014 Apr 25;348:g2636. doi: 10.1136/bmj.g2636.
6
Disgusted, embarrassed, annoyed: affective associations relate to uptake of colonoscopy screening.
Ann Behav Med. 2014 Aug;48(1):112-9. doi: 10.1007/s12160-013-9580-9.
9
Patients' expectations of screening and preventive treatments.
Ann Fam Med. 2012 Nov-Dec;10(6):495-502. doi: 10.1370/afm.1407.
10
How a charity oversells mammography.
BMJ. 2012 Aug 2;345:e5132. doi: 10.1136/bmj.e5132.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验